Newsletter | November 23, 2021

11.23.21 -- Strategies To Achieve Accelerated Drug Development Timelines

Redefining Speed In Drug Development

An effective platform requires a CDMO team with deep expertise across not only cell line and process development, but supply chains, engineering, commercial processing, and manufacturing technology.

Speed Matters: The Value Of Reducing Your Drug Development Timeline

Not many biologics make it to the finish line, and even then, regulatory approval is no guarantee of success — unless you win the race. Those to market first get the lion’s share of revenue for years to come and have a huge advantage over later entrants.

Achieving Accelerated Tech Transfer: Development To Manufacturing

Tech transfer timelines can be reduced by several months when empowered by a strong partnership between the sending site and the receiving site, built on careful planning and clear communication.

Continuous Manufacturing Technology To Existing Process: Challenges And Advantages Of Implementing N-1 Perfusion Technology

Discover key considerations and challenges in implementing N-1 perfusion technology as well as the impact of continuous technology on tech transfer and process scale-up.

Samsung Biologics, Your End-To-End CDMO Service Provider

Samsung Biologics is a reliable partner for seamless tech transfers, clinical and commercial manufacturing, aseptic fill/finish, and analytical testing. Committed to partnership, you will have a dedicated project management team walking you through your product’s entire development and manufacturing journey. We are committed to operational excellence in cGMP manufacturing and quality assurance.

Request Information